Copy link
Increase text size
Decrease text size
Link copied

EY to utilize Guardtime’s blockchain, Sensyne Health’s AI for outcome-based health payments

Wed, 26 Jun 2019, 06:52 am UTC

EY, an international assurance, tax, and advisory company, has partnered with artificial intelligence (AI) firm Sensyne Health and enterprise blockchain company Guardtime to tie medicine payments to clinical treatment success and patient satisfaction, in a so-called outcomes-based contracting.

According to its press release, the collaboration will work towards the expansion of the Health Outcomes Assessment platform, the first of its kind in the healthcare industry, to enable the platform to scale faster, resulting in “fairer reimbursement and access to novel treatments for patients.”

Under the collaboration, Sensyne Health will use AI to clinically assess the impact of medicine on the health of patients. On the other hand, Guardtime will allow transparent data to be shared between pharmaceutical companies and health providers and provide an audit trail for each viewed and used data. It will use its HSX bridge software built on the KSI blockchain.

Guardtime’s KSI blockchain technology will help ensure patient-level data visibility without compromising data privacy, helping to ensure all participants can collaborate securely and with confidence,” Guardtime CEO Mike Gault said.

In addition, EY will see itself bringing independent contract assessment, contract management, and automated business process experience and help deal with real-world outcomes-based contracts while maintaining transparency and trust.

We are delighted to be working to deliver the triple win: with life sciences companies increasing access to medicines, health care providers achieving greater efficiency and effectiveness and, most importantly, more patients getting better health outcomes,” Dan Matthews, EY EMEIA Life Sciences Leader, said.

Just recently, Arizona Care Network will soon allow patients with diabetes to use a healthcare blockchain network to manage the disease and optimize care with their physicians and families, using a platform collaborated by Solve.Care and Boehringer Ingelheim.

<Copyright © TokenPost. All Rights Reserved. >

To leave a comment, please sign in.
  • Bitcoin (BTC) $11,891.00 (+2.49%)
  • Ethereum (ETH) $398.12 (+2.39%)
  • XRP (XRP) $0.224600 (+0.84%)
  • Bitcoin Cash (BCH) $303.97 (+2.09%)
  • Chainlink (LINK) $13.46 (-4.49%)
  • Bitcoin (BTC) $11,891.00 (+2.49%)
Feb 21, 2020 (Friday)
Paxos launches blockchain-based securities settlement solution with Credit Suisse and Instinet
Brazil to launch new payment system in response to cryptocurrencies
Digital currency exchange Coinbase Pro lists Kyber Network token
Norwegian Air to soon start accepting crypto payments
Swedish central bank begins CBDC pilot with Accenture
Italian soccer team Juventus launches ethereum-based digital collectibles with Sorare
Feb 20, 2020 (Thursday)
Telecom companies complete cross-carrier mobile payments using blockchain
National Stock Exchange of Australia to develop DLT-based digital securities trading platform
South Korean ICO project discontinued, to return $7.5M to token holders
Samsung maintains crypto support in soon-to-launch Galaxy S20
BIS appoints Innovation Hub heads to lead Singapore and Switzerland
Coinbase becomes first crypto company to receive Visa principal membership
Dubai Economy and six banks launch KYC Blockchain Consortium
Crypto Technicals: ETH/USD under downside pressure after 'Bearish Engulfing' pattern
Tim Draper buys $1M worth of Aragon Tokens to create digital courts for DAOs
Renewable energy firm Acciona commits to take CBI’s blockchain-based carbon credits trading platform global
Crypto Technicals: BTC/USD trades below 21-EMA, break below 4H 200 MA (9386) to trigger further downside
Crypto exchange Coinfloor to launch a simplified bitcoin buying service
Indonesia’s customs department joins IBM- Maersk blockchain shipping platform “TradeLens”
Feb 19, 2020 (Wednesday)
Crypto custodian BitGo acquires digital securities startup Harbor
Subscribe to the TokenPost newsletter!
Don't show me this again today.
Back to top
Copyright ⓒ TokenPost. All Rights Reserved.